Year: 2019

In vivo determination of drug localization in tissue can be uniquely informative to drug developers investigating distribution within the context of...

Though there is no ‘roadmap’ spelling out required studies to achieve regulatory approval for clinical entry, a drug candidate’s metabolism...

ADME studies are a vital part of the drug development process, and therefore, deciding where and how to perform these studies...

In vivo mass balance studies are an important element of nonclinical drug development, to inform first in-human (FIH) studies and to...

As a drug moves through the development pipeline, it undergoes a rigorous battery of safety assessments to prove it will...

Because each new drug is unique in characteristics, such as chemical structure, mechanism of action, and physicochemical properties, there can...

A quantitative whole body autoradiography (QWBA) study provides data required for Human Radiolabeled ADME Studies1. Quantitative whole body autoradiography (QWBA) is an in...

XenoTech has been named the Best In Vitro Drug CRO in the 2019 Healthcare & Pharmaceutical Awards. From the release:...

Test systems for DMPK in vitro studies are part of the very foundation of our company. Our labs were borne of...

Science Exchange stated, “Discovery research programs at growing biotech companies are demanding—R&D leaders must balance the need to innovate with...